表紙
市場調査レポート

D型肝炎:世界の治験レビュー

Hepatitis D Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 320837
出版日 ページ情報 英文 58 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
D型肝炎:世界の治験レビュー Hepatitis D Global Clinical Trials Review, H2, 2014
出版日: 2014年11月30日 ページ情報: 英文 58 Pages
概要

当レポートでは、D型肝炎の臨床試験に関連する基本情報やデータを提供しており、試験件数および被験者の募集状況、段階別の動向、臨床試験を実施している主な製薬企業および研究機関のプロファイルなどをまとめています。

イントロダクション

  • D型肝炎
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:D型肝炎の感染症の治験における割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:D型肝炎の感染症の治験における割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

D型肝炎治療薬の治験に携わっている主要企業

有望な薬剤

最新の治験ニュース

治験のプロファイル

  • 主要企業の治験の概要
    • F. Hoffmann-La Roche Ltd.
    • Eiger BioPharmaceuticals, Inc.
    • REPLICor Inc.
    • MYR GmbH
    • Merck & Co., Inc.
    • Hepatera LLC
    • C. H. Boehringer Sohn AG & Co. KG
  • 代表的な研究機関・病院の治験の概要
    • The National Institute of Diabetes and Digestive and Kidney Diseases
    • German Liver Foundation
    • National Taiwan University Hospital

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2451CTIDB

GlobalData's clinical trial report, "Hepatitis D Global Clinical Trials Review, H2, 2014" provides data on the Hepatitis D clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatitis D. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatitis D. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Hepatitis D
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Hepatitis D to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Hepatitis D to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Hepatitis D Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Hepatitis D
    • Oct 01, 2014: REPLICor announces initiation of its Phase II clinical trial with REP 2139-Ca in combination with Pegasys in patients with hepatitis B / hepatitis D co-infection
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Eiger BioPharmaceuticals, Inc.
      • Clinical Trial Overview of Eiger BioPharmaceuticals, Inc.
      • REPLICor Inc.
      • Clinical Trial Overview of REPLICor Inc.
      • MYR GmbH
      • Clinical Trial Overview of MYR GmbH
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Hepatera LLC
      • Clinical Trial Overview of Hepatera LLC
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Diabetes and Digestive and Kidney Diseases
      • Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases
      • German Liver Foundation
      • Clinical Trial Overview of German Liver Foundation
      • National Taiwan University Hospital
      • Clinical Trial Overview of National Taiwan University Hospital
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Hepatitis D Therapeutics, Global, Clinical Trials by Region, 2014*
  • Hepatitis D Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Hepatitis D Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Hepatitis D Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Hepatitis D Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Hepatitis D Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Hepatitis D Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Hepatitis D to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Hepatitis D Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Hepatitis D Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Hepatitis D to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Hepatitis D Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Hepatitis D Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Hepatitis D Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Hepatitis D Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Hepatitis D Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Hepatitis D Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Hepatitis D Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Hepatitis D Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Hepatitis D Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Hepatitis D Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Hepatitis D Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by Eiger BioPharmaceuticals, Inc., 2014*
  • Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by REPLICor Inc., 2014*
  • Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by MYR GmbH, 2014*
  • Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by Hepatera LLC, 2014*
  • Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014*
  • Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2014*
  • Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by German Liver Foundation, 2014*
  • Hepatitis D Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014*

List of Figures

  • Hepatitis D Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Hepatitis D Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Hepatitis D Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Hepatitis D Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Proportion of Hepatitis D to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Hepatitis D Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Hepatitis D Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Hepatitis D to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Hepatitis D Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Hepatitis D Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Hepatitis D Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Hepatitis D Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Hepatitis D Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Hepatitis D Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Hepatitis D Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Hepatitis D Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Hepatitis D Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Hepatitis D Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Hepatitis D Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top